Bringing translational structure to complex immune-mediated conditions: the ACT (Activation–Constraint–Tissue Context) framework for divergent phenotypes

Immune-mediated outcomes diverge across individuals with similar genetic backgrounds and environmental exposures, reflecting trajectories through a dynamic, context-dependent, and partially stochastic state space rather than fixed molecular endpoints. Despite advances in systems immunology, computational modeling, and multi-omic profiling, translating this complexity into clinically actionable reasoning remains difficult: these disciplines generate increasingly detailed representations of immune behavior that deepen mechanistic understanding while raising barriers to integration across clinical, experimental, and computational domains. A clinician at the bedside cannot reason across tens of thousands of molecular variables, cell states, pathways, and contextual modifiers simultaneously. We adopt a reduction-oriented perspective — not because immune data are insufficient, but because high-dimensional biological information must be organized into a reduced representational space before it can support cross-domain reasoning. When a system is too complex to reason about directly, progress may depend on identifying a minimal set of variables that preserves explanatory power while enabling tractable inference. Rather than modeling the immune system in full mechanistic detail, we seek a constrained representation capturing the minimal structure necessary to characterize clinically observable immune phenotypes, consistent with principles from state-space modeling, dimensionality reduction, and systems biology. Here, we introduce ACT — Activation, Constraint, and Tissue Context — a reduced-dimensional immune phenotype space for reasoning about immune state across systemic and tissue-localized compartments. Within ACT, clinical observations, laboratory measurements, and multi-omic data are interpreted as projections of a latent immune state that evolves over time under environmental influence, host predisposition, therapeutic intervention, tissue context, and stochastic perturbation. Immune phenotype is thus represented not as a static label, but as a trajectory through reduced immune-state space. ACT does not infer molecular mechanism directly from phenotypic or reduced-state data. Instead, it provides a structured mapping from data to state, state to trajectory, and trajectory to pathway-level hypothesis generation — linking parsimonious state representation with trajectory-based reasoning to offer a conceptual scaffold for translating between clinical observation, multi-omic data, and pathway-level hypothesis generation in complex immune-mediated conditions. The goal is not to replace high-resolution molecular data, systems immunology, or mechanistic modeling, but to provide a common translational coordinate system for reasoning about immune phenotype across scales of observation and disciplinary boundaries — supporting communication, interpretation, and hypothesis generation across clinical, experimental, and computational domains.